178 related articles for article (PubMed ID: 36825298)
1. Recanalization Rate and Clinical Outcomes of Intravenous Tissue Plasminogen Activator Administration for Large Vessel Occlusion Stroke Patients.
Lee MH; Im SH; Jo KW; Yoo DS
J Korean Neurosurg Soc; 2023 Mar; 66(2):144-154. PubMed ID: 36825298
[TBL] [Abstract][Full Text] [Related]
2. Clinical Results of the Intra-Arterial Thrombolysis with Stent Retriever Device Weather Perfusion Diffusion Mismatching and Intravenous Tissue Plasminogen Activator Administration.
Kim YJ; Cho KW; Kim SR; Yoo DS; Park HK; Ji C
J Cerebrovasc Endovasc Neurosurg; 2017 Dec; 19(4):257-267. PubMed ID: 29387626
[TBL] [Abstract][Full Text] [Related]
3. Clinical results of intraarterial thrombolysis according to tPA administration and perfusion/diffusion mismatching.
Won YD; Lee TK; Kim YJ; Chun CW; Yoo DS; Jun SS
Acta Neurochir (Wien); 2015 Mar; 157(3):389-98. PubMed ID: 25585838
[TBL] [Abstract][Full Text] [Related]
4. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
[TBL] [Abstract][Full Text] [Related]
5. IV vs. IA TPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study.
Sen S; Huang DY; Akhavan O; Wilson S; Verro P; Solander S
Neurocrit Care; 2009; 11(1):76-81. PubMed ID: 19277904
[TBL] [Abstract][Full Text] [Related]
6. Effect of race/ethnicity on arterial recanalization following intravenous thrombolysis in acute ischemic stroke patients.
Fakih R; Ma X; Lodhi A; Bains N; French BR; Siddiq F; Gomez CR; Qureshi AI
J Stroke Cerebrovasc Dis; 2023 Sep; 32(9):107218. PubMed ID: 37453215
[TBL] [Abstract][Full Text] [Related]
7. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
[TBL] [Abstract][Full Text] [Related]
8. Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study.
Marks MP; Olivot JM; Kemp S; Lansberg MG; Bammer R; Wechsler LR; Albers GW; Thijs V;
Radiology; 2008 Nov; 249(2):614-23. PubMed ID: 18936316
[TBL] [Abstract][Full Text] [Related]
9. A Moving Target? The Fate of Large Vessel Occlusion Strokes Pretreated with Intravenous Tissue Plasminogen Activator in the Era of Mechanical Thrombectomy.
Rajah G; Saber H; Lieber B; Kappel A; Smitt M; Chamiraju P; Narayanan S; Luqman A
World Neurosurg; 2020 Sep; 141():e447-e452. PubMed ID: 32474091
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic results of intra-arterial thrombolysis after full-dose intravenous tissue plasminogen activator administration.
Yoo DS; Won YD; Huh PW; Shin HE; Kim KT; Kang SG; Lee SB; Cho KS
AJNR Am J Neuroradiol; 2010 Sep; 31(8):1536-40. PubMed ID: 20395391
[TBL] [Abstract][Full Text] [Related]
11. Approaches to and outcomes of intra-arterial tPA in embolectomy for large vessel occlusion.
Kohli GS; Whyte R; Schartz D; Rahmani R; Ellens NR; Susa ST; Bhalla T; Mattingly TK; Bender MT
J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106717. PubMed ID: 35994881
[TBL] [Abstract][Full Text] [Related]
12. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
Skagen K; Skjelland M; Russell D; Jacobsen EA
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156
[TBL] [Abstract][Full Text] [Related]
13. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.
Lewandowski CA; Frankel M; Tomsick TA; Broderick J; Frey J; Clark W; Starkman S; Grotta J; Spilker J; Khoury J; Brott T
Stroke; 1999 Dec; 30(12):2598-605. PubMed ID: 10582984
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Tissue Plasminogen Activator in Combination With Mechanical Thrombectomy: Clot Migration, Intracranial Bleeding, and the Impact of "Drip and Ship" on Effectiveness and Outcomes.
Chang A; Beheshtian E; Llinas EJ; Idowu OR; Marsh EB
Front Neurol; 2020; 11():585929. PubMed ID: 33424741
[No Abstract] [Full Text] [Related]
15. Intravenous tPA (Tissue-Type Plasminogen Activator) Correlates With Favorable Venous Outflow Profiles in Acute Ischemic Stroke.
Faizy TD; Mlynash M; Marks MP; Christensen S; Kabiri R; Kuraitis GM; Broocks G; Winkelmeier L; Geest V; Nawabi J; Lansberg MG; Albers GW; Fiehler J; Wintermark M; Heit JJ
Stroke; 2022 Oct; 53(10):3145-3152. PubMed ID: 35735008
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Distal Clot Migration during Mechanical Thrombectomy of Anterior Circulation Large Vessel Occlusion.
Mohammaden MH; Stapleton CJ; Brunozzi D; Khedr EM; Theiss P; Atwal G; Alaraj A
Cerebrovasc Dis; 2020; 49(2):185-191. PubMed ID: 32224607
[TBL] [Abstract][Full Text] [Related]
17. IV tPA given in the golden hour for emergent large vessel occlusion stroke improves recanalization rates and clinical outcomes.
Di Lorenzo R; Saqqur M; Buletko AB; Handshoe LS; Mulpur B; Hardman J; Donohue M; Wisco D; Uchino K; Hussain MS
J Neurol Sci; 2021 Sep; 428():117580. PubMed ID: 34280605
[TBL] [Abstract][Full Text] [Related]
18. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers.
Imbarrato G; Bentley J; Gordhan A
J Neurosci Rural Pract; 2018; 9(2):240-244. PubMed ID: 29725176
[TBL] [Abstract][Full Text] [Related]
20. Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment.
Flint AC; Avins AL; Eaton A; Uong S; Cullen SP; Hsu DP; Edwards NJ; Reddy PA; Klingman JG; Rao VA; Chan SL; Hartman J; Zrelak PA; Nguyen-Huynh MN
Stroke; 2020 Sep; 51(9):2697-2704. PubMed ID: 32757749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
